COST vs STRO
Costco Wholesale Corp (COST) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. Revenue was up 8.2% from 2024-09-01 to 2025-08-31. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
COST currently screens at market cap $430.32B and trailing P/E 54.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the COST and STRO stock pages for the full models.
Not investment advice.